Countries North America
Ferring Pharmaceuticals Reports Real World Evidence Supporting ADSTILADRIN Re Induction In BCG Unresponsive Bladder Cancer
Re-induction with ADSTILADRIN resulted in complete responses in 31% of initial non-responders with Bacillus Calmette-Guérin (BCG)-unresponsive n...
May 19, 2026 | News
ImmunityBio Secures Exclusive US Rights To Tokyo Strain BCG To Address Chronic Bladder Cancer Treatment Shortage
Positive Phase III readout of National Cancer Institute sponsored SWOG S1602 randomized clinical trial demonstrating non-inferior efficacy of the Tokyo...
May 19, 2026 | News
AstraZeneca And Daiichi Sankyo Expand ENHERTU Into Early HER2 Positive Breast Cancer Treatment In The US
Approved for use before surgery based on DESTINY-Breast11 Phase III trial Approved for use following surgery based on DESTINY-Breast05 Phase III trial ...
May 19, 2026 | News
Piramal Pharma Solutions Expands US ADC Manufacturing Capability With New Payload Linker Suite In Michigan
The Riverview facility provides comprehensive services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), including specialized...
May 15, 2026 | News
IQVIA And Kexing Biopharm Advance Global Biosimilar Expansion Through AI Enabled Strategic Collaboration
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthc...
May 15, 2026 | News
FDA Approves First All Oral INQOVI Plus Venetoclax Regimen For Newly Diagnosed AML Patients Ineligible For Intensive Chemotherapy
Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration (FDA) has approved INQOVI (decitabine and ced...
May 15, 2026 | News
GenScript Biotech Launches TurboCHO Protein Expression Kit To Accelerate Antibody Discovery Workflows
New kit offers researchers and development teams a meaningful advance in expression speed and output GenScript Biotech Corporation announced the laun...
May 14, 2026 | News
Curocell And ProBio Achieve Korean Milestone With Approval Of Next Generation CAR T Therapy Anbal cel
Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation Given the accelerating global momentum in CAR-T and gene th...
May 13, 2026 | News
Benchling Launches Antibody R&D Platform To Accelerate Biologics Discovery And Development
Benchling announced Benchling Biologics, an end-to-end platform for antibody R&D, today at the PEGS Boston Summit. Scientists can configure a...
May 13, 2026 | News
Hengrui Pharma And Bristol Myers Squibb Forge $15.2 Billion Strategic Alliance Across Oncology And Immunology
Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide Agreement...
May 13, 2026 | News
Medit Expands Into Orthodontics With Acquisition Of Progressive Orthodontics
Global digital dentistry leader expands into orthodontics by combining proprietary technology with one of the world's leading clinical education platforms ...
May 12, 2026 | News
ACROBiosystems Simplifies Global HEK293 Licensing To Accelerate Biopharma R&D Compliance
ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrat...
May 11, 2026 | News
Alebund Completes Global Phase III Enrollment For AP301 In Hyperphosphatemia Trial
Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies...
May 07, 2026 | News
Cellenkos Advances CK0802 Into Phase 1b 2a Trial Following FDA Clearance For Steroid Refractory GVHD
Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf Treg therapy, in patients with s...
May 06, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
